Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series
Main Authors: | Elif Karatas, MD, Ali Nazim, BS, Parth Patel, MD, Toral Vaidya, MD, MPH, George Scott Drew, DO, Sanober A. Amin, MD, PhD, Ashley A. Keyes, MD, Maira Fonseca, MD, Adnan Mir, MD, PhD, Caroline P. Halverstam, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512621009024 |
Similar Items
-
Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases
by: Massimo Petruzzi, et al.
Published: (2022-03-01) -
Erythema multiforme associated with Entamoeba histolytica
by: Karyn Haitz, MD, et al.
Published: (2021-01-01) -
Treatment of recurrent erythema multiforme with adalimumab as monotherapy
by: Bryan Baillis, MD, et al.
Published: (2017-03-01) -
Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine
by: Giovanni Paolino, MD, PhD, et al.
Published: (2022-03-01) -
Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approach
by: Alana Deutsch, MD, et al.
Published: (2023-04-01)